| 1 (8) | Samsung Corp * | MUL |  |
| 2 (18) | IBM Research * | MUL |  |
| 3 (45) | Microsoft Corp * | MUL |  |
| 4 (48) | Toyota Group * | MUL |  |
| 5 (51) | European Commission * | MUL |  |
| 6 (56) | European Commission - Joint Research Centre | MUL |  |
| 7 (96) | Novo Nordisk * | MUL |  |
| 8 (102) | GlaxoSmithKline * | MUL |  |
| 9 (149) | Aramco * | MUL |  |
| 9 (149) | F Hoffmann-La Roche * | MUL |  |
| 11 (184) | Merck * | MUL |  |
| 12 (248) | Shell * | MUL |  |
| 13 (256) | General Electric Company * | MUL |  |
| 14 (260) | Robert Bosch * | MUL |  |
| 15 (269) | Mitsubishi Corp * | MUL |  |
| 16 (270) | International Centre for Genetic Engineering and Biotechnology * | MUL |  |
| 17 (277) | Siemens * | MUL |  |
| 18 (288) | Novartis * | MUL |  |
| 19 (313) | BASF Group * | MUL |  |
| 20 (315) | Schlumberger * | MUL |  |
| 21 (371) | Nippon Telegraph and Telephone Corporation * | MUL |  |
| 22 (384) | DowDupont * | MUL |  |
| 23 (404) | Ford Motor Company * | MUL |  |
| 24 (405) | Procter & Gamble Co * | MUL |  |
| 25 (414) | Netherlands Organisation for Applied Scientific Research * | MUL |  |
| 26 (418) | Johnson & Johnson * | MUL |  |
| 26 (418) | AstraZeneca * | MUL |  |
| 28 (454) | European Space Agency * | MUL |  |
| 29 (456) | Dow Chemical Co | MUL |  |
| 30 (468) | Volkswagen AG * | MUL |  |
| 31 (489) | Heriot-Watt University * | MUL |  |
| 32 (492) | Bayer * | MUL |  |
| 33 (496) | Syngenta * | MUL |  |
| 34 (503) | ExxonMobil * | MUL |  |
| 35 (523) | Unilever * | MUL |  |
| 36 (530) | TOTAL * | MUL |  |
| 37 (536) | Hitachi * | MUL |  |
| 38 (543) | Honda Motor Co Ltd * | MUL |  |
| 39 (547) | Sumitomo Group * | MUL |  |
| 40 (550) | Laureate International Universities * | MUL |  |
| 41 (558) | Pfizer * | MUL |  |
| 42 (571) | Petrobras * | MUL |  |
| 43 (576) | Equinor ASA * | MUL |  |
| 44 (616) | General Motors Company * | MUL |  |
| 45 (617) | Hyundai Motor Group * | MUL |  |
| 46 (620) | Corteva | MUL |  |
| 47 (672) | Manipal Global Education Group * | MUL |  |
| 48 (686) | Tata Group * | MUL |  |
|